Ali Kiadaliri

Docent, Forskare, Biträdande, ,
Fler filtreringsmöjligheter
Fler filtreringsmöjligheter

Alla författare

Återställ
till
1 - 50 av 125Sidstorlek: 50

  2. Cost-Effectiveness Analysis Of Cancer Treatments In South Of Iran

    Aliasghar Ahmad Kiadaliri, P. Bastani, N. Hatam & N. Ahmadloo, 2010, I : Value in Health. 13, 7, s. A267-A268

    Forskningsoutput: Tidskriftsbidrag › Publicerat konferensabstract

  3. QUALITY OF LIFE AFTER CHEMOTHERAPY IN BREAST CANCER: A STUDY IN SOUTH OF IRAN

    Aliasghar Ahmad Kiadaliri & P. Bastani, 2010, I : Value in Health. 13, 7, s. A277-A277

    Forskningsoutput: Tidskriftsbidrag › Publicerat konferensabstract

  6. Health utilities of type 2 diabetes-related complications: a cross-sectional study in sweden.

    Aliasghar Ahmad Kiadaliri, Ulf Gerdtham, Björn Eliasson, Soffia Gudbjörnsdottir, Ann-Marie Svensson & Katarina Steen Carlsson, 2014, I : International Journal of Environmental Research and Public Health. 11, 5, s. 4939-4952

    Forskningsoutput: Tidskriftsbidrag › Artikel i vetenskaplig tidskrift

  7. Pure and social disparities in distribution of dentists: a cross-sectional province-based study in iran.

    Aliasghar Ahmad Kiadaliri, Reza Hosseinpour, Hassan Haghparast-Bidgoli & Ulf Gerdtham, 2013, I : International Journal of Environmental Research and Public Health. 10, 5, s. 1882-1894

    Forskningsoutput: Tidskriftsbidrag › Artikel i vetenskaplig tidskrift

  11. Towards a Health Economic Simulation Model of Type 2 Diabetes in Sweden

    Aliasghar Ahmad Kiadaliri, 2014, Health Economics. 57 s.

    Forskningsoutput: Avhandling › Doktorsavhandling (sammanläggning)

  12. Quality of life in people with diabetes: a systematic review of studies in Iran.

    Aliasghar Ahmad Kiadaliri, Baharak Najafi & Maryam Mirmalek-Sani, 2013, I : Journal of Diabetes & Metabolic Disorders. 12, 1, 54.

    Forskningsoutput: Tidskriftsbidrag › Översiktsartikel

  14. Overall, gender and social inequalities in suicide mortality in Iran, 2006-2010: a time trend province-level study.

    Aliasghar Ahmad Kiadaliri, Soheil Saadat, Hossein Shahnavazi & Hassan Haghparast-Bidgoli, 2014, I : BMJ Open. 4, 8, s. e005227

    Forskningsoutput: Tidskriftsbidrag › Artikel i vetenskaplig tidskrift

  15. Measuring Efficiency of General Hospitals in the South of Iran

    Aliasghar Ahmad Kiadaliri, Hassan Haghparast-Bidgoli & Asghar Zarei, 2011, I : World Applied Sciences Journal. 13, 6, s. 1310-1316

    Forskningsoutput: Tidskriftsbidrag › Artikel i vetenskaplig tidskrift

  18. The prevalence of adulthood overweight and obesity in Tehran: findings from Urban HEART-2 study.

    Aliasghar Ahmad Kiadaliri, Mehdi Jafari, Mohammad-Reza Vaez Mahdavi, Soghrat Faghihzadeh, Naser Kalantari & Mohsen Asadi-Lari, 2015, I : Medical Journal of the Islamic Republic of Iran. 29, 178, s. 1-9

    Forskningsoutput: Tidskriftsbidrag › Artikel i vetenskaplig tidskrift

  19. Geographic distribution of need and access to health care in rural population: an ecological study in Iran

    Aliasghar Ahmad Kiadaliri, Behzad Najafi & Hassan Haghparast-Bidgoli, 2011, I : International Journal for Equity in Health. 10, 39

    Forskningsoutput: Tidskriftsbidrag › Artikel i vetenskaplig tidskrift

  21. Absolute and relative educational inequalities in obesity among adults in Tehran: Findings from the Urban HEART study-2.

    Aliasghar Ahmad Kiadaliri, Mohsen Asadi-Lari, Naser Kalantari, Mehdi Jafari, Mohammad Reza Vaez Mahdavi & Soghrat Faghihzadeh, 2015, I : Obesity Research and Clinical Practice.

    Forskningsoutput: Tidskriftsbidrag › Artikel i vetenskaplig tidskrift

  22. The impact of factor VIII inhibitors on factor consumption in haemophilia: a case-control study in the south of Iran

    Aliasghar Ahmad Kiadaliri, Kimia Pourmohammadi, Peivand Bastani & Mehran Karimi, 2011, I : Middle-East Journal of Scientific Research. 8, 3, s. 694-698

    Forskningsoutput: Tidskriftsbidrag › Artikel i vetenskaplig tidskrift

  23. Health-Related Quality of Life of Breast Cancer Patients in Iran: Pooled Analysis using Generalized Estimating Equations.

    Aliasghar Ahmad Kiadaliri, Peivand Bastani & Hossein Ibrahimipour, 2012, I : Asian Pacific Journal of Cancer Prevention. 13, 3, s. 941-944

    Forskningsoutput: Tidskriftsbidrag › Artikel i vetenskaplig tidskrift

  24. Cost-effectiveness of prophylaxis against on-demand treatment in boys with severe hemophilia A in Iran.

    Aliasghar Ahmad Kiadaliri, Hassan Haghparast & Jahanara Mamikhani, 2009, International Journal of Technology Assessment in Health Care, 25, 4, s. 584-587.

    Forskningsoutput: Bidrag till övrig tidskrift/dags- eller nyhetstidning › Artikel i facktidskrift eller populärpress

  25. Technical efficiency of public hospitals in Khuzestan province, Iran

    Aliasghar Ahmad Kiadaliri & Asghar Zarei, 2009.

    Forskningsoutput: Konferensbidrag › Konferensabstract

  26. Geographical distribution of rural health houses in provinces of Iran.

    Aliasghar Ahmad Kiadaliri, Hassan Haghparast, Hamidreza Safari & Behzad Najafi, 2010.

    Forskningsoutput: Konferensbidrag › Konferensabstract

  27. Geographic Distribution of CCU beds in Iran.

    Aliasghar Ahmad Kiadaliri, Hamidreza Safari & Reza Hoseinpour, 2010.

    Forskningsoutput: Konferensbidrag › Konferensabstract

  28. The impact of inhibitors on the cost of clotting factor replacement therapy in hemophilia A in south of Iran.

    Aliasghar Ahmad Kiadaliri, M. Karimi, K. Pourmohammadi & P. Bastani, 2009.

    Forskningsoutput: Konferensbidrag › Konferensabstract

  32. Assessing the external validity of algorithms to estimate EQ-5D-3L from the WOMAC

    Aliasghar Ahmad Kiadaliri & Martin Englund, 2016 okt 4, I : Health and Quality of Life Outcomes. 14, 1, 141.

    Forskningsoutput: Tidskriftsbidrag › Artikel i vetenskaplig tidskrift

  33. Global, regional, and national levels of maternal mortality, 1990-2015: a systematic analysis for the Global Burden of Disease Study 2015

    GBD 2015 Maternal Mortality Collaborators GBD 2015 Maternal Mortality Collaborators, 2016 okt 8, I : The Lancet. 388, 10053, s. 1775-1812 38 s.

    Forskningsoutput: Tidskriftsbidrag › Artikel i vetenskaplig tidskrift

  34. Global, regional, and national comparative risk assessment of 79 behavioural, environmental and occupational, and metabolic risks or clusters of risks, 1990-2015: a systematic analysis for the Global Burden of Disease Study 2015

    GBD 2015 Risk Factors Collaborators GBD 2015 Risk Factors Collaborators, 2016 okt 8, I : The Lancet. 388, 10053, s. 1659-1724

    Forskningsoutput: Tidskriftsbidrag › Artikel i vetenskaplig tidskrift

  35. Global, regional, and national disability-adjusted life-years (DALYs) for 315 diseases and injuries and healthy life expectancy (HALE), 1990-2015: a systematic analysis for the Global Burden of Disease Study 2015

    GBD 2015 DALYs and HALE Collaborators GBD 2015 DALYs and HALE Collaborators, 2016 okt 8, I : The Lancet. 388, 10053, s. 1603-1658 56 s.

    Forskningsoutput: Tidskriftsbidrag › Artikel i vetenskaplig tidskrift

  36. Global, regional, and national incidence, prevalence, and years lived with disability for 310 diseases and injuries, 1990-2015: a systematic analysis for the Global Burden of Disease Study 2015

    GBD 2015 Disease and Injury Incidence and Prevalence Collaborators GBD 2015 Disease and Injury Incidence and Prevalence Collaborators, 2016 okt 8, I : The Lancet. 388, 10053, s. 1545-1602

    Forskningsoutput: Tidskriftsbidrag › Artikel i vetenskaplig tidskrift

  37. Global, regional, and national life expectancy, all-cause mortality, and cause-specific mortality for 249 causes of death, 1980-2015: a systematic analysis for the Global Burden of Disease Study 2015

    GBD 2015 Mortality and Causes of Death Collaborators GBD 2015 Mortality and Causes of Death Collaborators, 2016 okt 8, I : The Lancet. 388, 10053, s. 1459-1544 86 s.

    Forskningsoutput: Tidskriftsbidrag › Artikel i vetenskaplig tidskrift

  38. Measuring the health-related Sustainable Development Goals in 188 countries: a baseline analysis from the Global Burden of Disease Study 2015

    Bo Norrving & GBD 2015 SDG Collaborators GBD 2015 SDG Collaborators, 2016 okt 8, I : The Lancet. 388, 10053, s. 1813-1850

    Forskningsoutput: Tidskriftsbidrag › Artikel i vetenskaplig tidskrift

  41. Rheumatoid arthritis as underlying cause of death in 31 countries, 1987-2011: Trend analysis of WHO mortality database

    Aliasghar Ahmad Kiadaliri, David T. Felson, Tuhina Neogi & Martin Englund, 2017, I : Arthritis & Rheumatology. 69, 8, s. 1560-1565

    Forskningsoutput: Tidskriftsbidrag › Artikel i vetenskaplig tidskrift

  43. Future and potential spending on health 2015-40: development assistance for health, and government, prepaid private, and out-of-pocket health spending in 184 countries

    Global Burden of Disease Health Financing Collaborator Network Global Burden of Disease Health Financing Collaborator Network, 2017, I : The Lancet. 389, 10083, s. 2005-2030

    Forskningsoutput: Tidskriftsbidrag › Artikel i vetenskaplig tidskrift

  44. Evolution and patterns of global health financing 1995-2014: development assistance for health, and government, prepaid private, and out-of-pocket health spending in 184 countries

    Global Burden of Disease Health Financing Collaborator Network Global Burden of Disease Health Financing Collaborator Network, 2017, I : The Lancet. 389, 20-26, s. 1981-2004

    Forskningsoutput: Tidskriftsbidrag › Artikel i vetenskaplig tidskrift

  45. Healthcare Access and Quality Index based on mortality from causes amenable to personal health care in 195 countries and territories, 1990-2015: a novel analysis from the Global Burden of Disease Study 2015

    GBD 2015 Healthcare Access and Quality Collaborators GBD 2015 Healthcare Access and Quality Collaborators, 2017, I : The Lancet. 390, 10091, s. 231-266

    Forskningsoutput: Tidskriftsbidrag › Artikel i vetenskaplig tidskrift

  46. Global, regional, and national comparative risk assessment of 84 behavioural, environmental and occupational, and metabolic risks or clusters of risks, 1990-2016: a systematic analysis for the Global Burden of Disease Study 2016

    GBD 2016 Risk Factors Collaborators GBD 2016 Risk Factors Collaborators, 2017 sep 16, I : The Lancet. 390, 10100, s. 1345-1422 78 s.

    Forskningsoutput: Tidskriftsbidrag › Artikel i vetenskaplig tidskrift

  47. Global, regional, and national disability-adjusted life-years (DALYs) for 333 diseases and injuries and healthy life expectancy (HALE) for 195 countries and territories, 1990-2016: a systematic analysis for the Global Burden of Disease Study 2016

    GBD 2016 DALYs and HALE Collaborators GBD 2016 DALYs and HALE Collaborators, 2017 sep 16, I : The Lancet. 390, 10100, s. 1260-1344 85 s.

    Forskningsoutput: Tidskriftsbidrag › Artikel i vetenskaplig tidskrift

  48. Global, regional, and national incidence, prevalence, and years lived with disability for 328 diseases and injuries for 195 countries, 1990-2016: a systematic analysis for the Global Burden of Disease Study 2016

    GBD 2016 Disease and Injury Incidence and Prevalence Collaborators GBD 2016 Disease and Injury Incidence and Prevalence Collaborators, 2017 sep 16, I : The Lancet. 390, 10100, s. 1211-1259 49 s.

    Forskningsoutput: Tidskriftsbidrag › Artikel i vetenskaplig tidskrift

  49. Global, regional, and national age-sex specific mortality for 264 causes of death, 1980-2016: a systematic analysis for the Global Burden of Disease Study 2016

    GBD 2016 Causes of Death Collaborators GBD 2016 Causes of Death Collaborators, 2017 sep 16, I : The Lancet. 390, 10100, s. 1151-1210 60 s.

    Forskningsoutput: Tidskriftsbidrag › Artikel i vetenskaplig tidskrift

  50. Global, regional, and national under-5 mortality, adult mortality, age-specific mortality, and life expectancy, 1970-2016: a systematic analysis for the Global Burden of Disease Study 2016

    GBD 2016 Mortality Collaborators GBD 2016 Mortality Collaborators, 2017 sep 16, I : The Lancet. 390, 10100, s. 1084-1150 67 s.

    Forskningsoutput: Tidskriftsbidrag › Artikel i vetenskaplig tidskrift

Föregående 1 2 3 Nästa

Ali Kiadaliri

Docent, Forskare, Biträdande, ,

Affilieringar

Orcid

ORCID: 0000-0002-4254-9099
Ytterligare kontaktuppgifter